Gushengtang Holdings (HKG:2273) Full Year 2024 Results
Key Financial Results
- Revenue: CN¥3.02b (up 30% from FY 2023).
- Net income: CN¥306.8m (up 22% from FY 2023).
- Profit margin: 10% (in line with FY 2023).
- EPS: CN¥1.26 (up from CN¥1.06 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Gushengtang Holdings EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%.
Looking ahead, revenue is forecast to grow 20% p.a. on average during the next 3 years, compared to a 7.0% growth forecast for the Healthcare industry in Hong Kong.
Performance of the Hong Kong Healthcare industry.
The company's shares are down 8.3% from a week ago.
Risk Analysis
We don't want to rain on the parade too much, but we did also find 1 warning sign for Gushengtang Holdings that you need to be mindful of.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.